Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 09, 2023

SELL
$40.4 - $59.1 $1.16 Million - $1.7 Million
-28,730 Reduced 4.78%
572,353 $23.3 Million
Q1 2023

May 10, 2023

SELL
$38.16 - $48.86 $2.23 Million - $2.86 Million
-58,457 Reduced 8.86%
601,083 $29.1 Million
Q4 2022

Feb 10, 2023

SELL
$33.53 - $54.79 $2.43 Million - $3.96 Million
-72,350 Reduced 9.89%
659,540 $25.2 Million
Q3 2022

Nov 09, 2022

BUY
$41.85 - $53.85 $1.92 Million - $2.48 Million
45,990 Added 6.71%
731,890 $36.7 Million
Q2 2022

Aug 05, 2022

SELL
$25.6 - $45.23 $4.16 Million - $7.35 Million
-162,505 Reduced 19.15%
685,900 $27.5 Million
Q1 2022

May 06, 2022

SELL
$33.33 - $44.6 $7.82 Million - $10.5 Million
-234,500 Reduced 21.65%
848,405 $31.7 Million
Q4 2021

Feb 04, 2022

SELL
$35.36 - $41.86 $1.66 Million - $1.97 Million
-46,980 Reduced 4.16%
1,082,905 $43.1 Million
Q3 2021

Nov 08, 2021

SELL
$37.01 - $44.74 $884,539 - $1.07 Million
-23,900 Reduced 2.07%
1,129,885 $42 Million
Q2 2021

Aug 09, 2021

BUY
$37.95 - $49.37 $4.41 Million - $5.74 Million
116,315 Added 11.21%
1,153,785 $48.8 Million
Q1 2021

May 12, 2021

SELL
$46.8 - $68.92 $673,826 - $992,310
-14,398 Reduced 1.37%
1,037,470 $49.1 Million
Q4 2020

Feb 12, 2021

SELL
$47.96 - $67.64 $5.25 Million - $7.41 Million
-109,550 Reduced 9.43%
1,051,868 $64.2 Million
Q3 2020

Nov 06, 2020

BUY
$45.41 - $57.07 $7.53 Million - $9.46 Million
165,723 Added 16.64%
1,161,418 $54.3 Million
Q2 2020

Aug 07, 2020

BUY
$42.56 - $54.98 $2.87 Million - $3.7 Million
67,320 Added 7.25%
995,695 $50.5 Million
Q1 2020

May 08, 2020

BUY
$32.37 - $59.36 $9.75 Million - $17.9 Million
301,105 Added 48.0%
928,375 $41.4 Million
Q4 2019

Feb 05, 2020

BUY
$32.22 - $50.07 $20.2 Million - $31.4 Million
627,270 New
627,270 $30.1 Million

Others Institutions Holding PTCT

About PTC THERAPEUTICS, INC.


  • Ticker PTCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 71,541,000
  • Market Cap $3.31B
  • Description
  • PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...
More about PTCT
Track This Portfolio

Track Times Square Capital Management, LLC Portfolio

Follow Times Square Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Times Square Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Times Square Capital Management, LLC with notifications on news.